Startups: How to Avoid Being Squashed by Big Companies?

Lecture Description

Yock states that the best pathway has been the start-up. The best platform-shifting comes from these companies. Get some angels and venture companies to back you and then you're good to go, he says.

Course Index

1. The Accidental Entrepreneur
2. Biotech Bay: The Other Silicon Valley
3. Biotech: Interface Between Industry and University
4. Cardiovascular Disease vs. Bioterrorism
5. Beginning of Less Invasive Cardiac Techniques: Charles Dotter
6. History of Balloon Angioplasty Catheter: Thomas Fogarty
7. Coronary Angioplasty: Andreas Geruntzig
8. Guidewire Catheter: John Simpson
9. Mentoring Changed My Life
10. Testing Medical Devices and Overcoming FDA Hurdles
11. Restentosis and Stents: Just in Time Design
12. Using Stents as Drug Delivery System
13. Opportunity: How to Cover Economic Loss from Stent Use?
14. Medtech: What's Going on in Region and at Stanford
15. Interdisciplinary Biomed Education and Clark Center at Stanford
16. Identify the Need: Invention and Being Contrary
17. MedTech: Keep it Simple
18. Patents Dominate MedTech
19. FDA and Medicare
20. Think Big and Pay Close Attention to Market Assessment
21. Envisioning the Future in Medtech: Go Where the Puck Will Be
22. Who Does Non-surgical Procedures?
23. Medical Inventions: Physicians and Entrepreneurs in Partnership
24. How are Financials for Cardiac Surgery?
25. Cost vs. Price for Medical Stents?
26. Future of Robotics in Minimally Invasive Surgery?
27. Attributes of a Successful Entrepreneur in MedTech
28. What's the Future of Medical Diagnostics?
29. Who is Leading the Stent Market Today?
30. Startups: How to Avoid Being Squashed by Big Companies?
31. Convergence and Drug Delivery
32. Medical Devices and Nanotechnology
33. Scaling Technologies to the Developing World